Results 91 to 100 of about 10,757 (207)

Epithelial myoepithelial carcinoma of the parotid gland

Medical Journal of Dr. D.Y. Patil University, 2015
Epithelial-myoepithelial carcinoma (EMC) is a low-grade malignant tumor of the salivary glands. It is extremely rare neoplasm accounting for
Sachin A Badge, Nitin M Gangane, Vitaladevnni B Shivkumar, Satish M Sharma   +3 more
doaj   +1 more source

Secretory Carcinoma Mimicking a Mucocele: Case Report and Literature Update

Oral Surgery, EarlyView.
ABSTRACT Aim Secretory carcinoma (SC), also known as mammary analogue secretory carcinoma, is a rare malignant neoplasm of the salivary glands, named for its histological and molecular resemblance to mammary secretory carcinoma. The aim of this study is to present a new case of SC occurring in the lower lip, initially diagnosed as a mucocele, and to ...
Débora Frota Colares, André Luis Alves Borges, Leonardo Magalhães Carlan, Adriano Rocha Germano, Antônio de Lisboa Lopes Costa, Hébel Cavalcanti Galvão   +5 more
wiley   +1 more source

Pleomorphic adenoma in the cheek a rare finding

Journal of International Clinical Dental Research Organization, 2017
Pleomorphic adenoma, also known as the benign mixed tumor is the most common tumor of salivary gland origin, accounting for about 60% of all salivary tumors.
Deepak Kaul, Ashish Kailashsingh Rajput, Zubair Ahmed, Palak Umadiya   +3 more
doaj   +1 more source

Hybrid salivary gland tumor of the upper lip or just an adenoid cystic carcinoma? Case report [PDF]

, 2010
A 65 year-old male patient with a one year-duration tumoral growth located in the upper lip was diagnosed on incisional biopsy as epithelial-myoepithelial carcinoma.
Cano Valdez, Ana María, Luna Ortiz, Kuauhyama, Mosqueda Taylor, Adalberto, Ortega Gutierrez, Cesar, Ruiz Gonzalez, José Daniel Salvador   +4 more
core   +1 more source

A Very Rare Salivary Gland Tumor: Sialoblastoma

Plastic and Reconstructive Surgery, Global Open
Summary:. Children seldom develop salivary gland tumors, which account for less than 5% of all salivary gland tumors. In total, 10%–15% of these neoplasms arise from the submandibular, sublingual, and small salivary glands, with the parotid gland ...
Dagmawi G. Zinaw, MD, Ataklitie B. Berhea, MD, FCS, ECSA, Endale K. Aydeferu, MD, Tigist D. Beyera, MD   +3 more
doaj   +1 more source

Surgical Treatment Outcome of Salivary Gland Tumors

Journal of Baghdad College of Dentistry, 2019
Background: Salivary gland neoplasms constitute a group of heterogeneous lesions with complex clinicopathologic characteristics and distinct biological behavior.
Nibrass J. Kadhim, Salwan Y. Bede   +1 more
doaj   +1 more source

GH-secreting pituitary macroadenoma (acromegaly) associated with progressive dental malocclusion and refractory CPAP treatment [PDF]

, 2017
Background: A link between progressive dental malocclusion, the use of a continuous positive airway pressure mask and GH-secreting pituitary macroadenoma (acromegaly) has not been previously reported.
Brunet i Llobet, Lluís, Dios-Miranda, David de, Giménez Rubio, Josep Anton, Lahor i Soler, Eduard, Miranda i Rius, Jaume   +4 more
core   +2 more sources

Cohort study of standardized treatment pathways by multidisciplinary tumor board decision making in patients with salivary gland malignancies

International Journal of Cancer, Volume 158, Issue 12, Page 3241-3251, 15 June 2026.
What's new? The overall survival of patients with salivary gland malignancies has shown limited progress. Here, the authors evaluated the impact of establishing a multidisciplinary tumor board to ensure standardized diagnostic and treatment procedures at a certified cancer center.
Nils Feldmann, Gunnar Wichmann, Andreas Dietz, Markus Pirlich   +3 more
wiley   +1 more source

Rare Biphasic Tumor Myoepithelial Carcinoma of the Parotid Gland

Journal of Radiation and Cancer Research
An uncommon malignant salivary gland tumor is called epithelial–myoepithelial carcinoma. Less than 1% of all salivary gland neoplasms are caused by it. Donath et al. initially described these uncommon salivary gland tumors in 1972.
Mahima S. Shetty, V. S. Kavitha, Harsha Shaju, Trisha S. Shetty   +3 more
doaj   +1 more source

Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab‐paclitaxel

International Journal of Cancer, Volume 158, Issue 12, Page 3091-3100, 15 June 2026.
What's new? Adaptive immune responses are typically limited in pancreatic ductal adenocarcinoma, resulting in minimal efficacy of immune checkpoint inhibitors. Tumor Treating Fields (TTFields) therapy, which uses low‐intensity intermediate‐frequency electric fields to disrupt cancer cell processes, has been approved for certain cancers.
Tal Kan, Tharwat Haj Khalil, Yiftah Barsheshet, Tali Voloshin, Lilach Koren, Bella Koltun, Cfir David, Kerem Wainer‐Katsir, Avital Vorontsova, Boris Brant, Simona Zisman‐Rozen, Hila M. Ene, Roni Frechtel‐Gerzi, Shay Cahal, Anat Klein‐Goldberg, Lena Lifshitz, Efrat Zemer Tov, Mai Shai, Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti   +21 more
wiley   +1 more source